Wei Lü

机构：Central South University, Hubei University of Chinese Medicine, Nanjing University of Posts and Telecommunications, The People's Hospital Tongling, Jinhua Academy of Agricultural Sciences, Second Xiangya Hospital of Central South University, Tongling University, Shanghai Municipal Center For Disease Control Prevention, Jinhua Central Hospital, Nanjing Medical University · ORCID：0000-0001-7661-9975

发表论文 230 篇 · 总被引 1113 次 · h-index 17

代表论文

• Engineered microalgae for photo-sonodynamic synergistic therapy in breast cancer treatment (2024 · Acta Biomaterialia · 被引 31)
• Inhibition of USP7 enhances CD8+ T cell activity in liver cancer by suppressing PRDM1-mediated FGL1 upregulation (2024 · Acta Pharmacologica Sinica · 被引 21)
• Diosbulbin C, a novel active ingredient in Dioscorea bulbifera L. extract, inhibits lung cancer cell proliferation by inducing G0/G1 phase cell cycle arrest (2023 · BMC Complementary Medicine and Therapies · 被引 17)
• Tumor-intrinsic PRMT5 upregulates FGL1 via methylating TCF12 to inhibit CD8+ T-cell-mediated antitumor immunity in liver cancer (2024 · Acta Pharmaceutica Sinica B · 被引 13)
• A Novel Bifidobacterium/Klebsiella Ratio in Characterization Analysis of the Gut and Bile Microbiota of CCA Patients (2023 · Microbial Ecology · 被引 13)
• Zinc Transporters Serve as Prognostic Predictors and their Expression Correlates with Immune Cell Infiltration in Specific Cancer: A Pan-cancer Analysis (2024 · Journal of Cancer · 被引 10)